Related Experiment Video
Updated: Jun 5, 2025

12:44
Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
Published on: January 27, 2023
3.7K
Identification of ZNF652 as a Diagnostic and Therapeutic Target in Osteoarthritis Using Machine Learning
Yeping Chen1, Rongyuan Liang1, Xifan Zheng1
1Department of Bone and Joint Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
Journal of Inflammation Research
|December 9, 2024
Summary
Zinc Finger Protein 652 (ZNF652) is a novel biomarker for osteoarthritis (OA). This study identified ZNF652 as a key diagnostic and therapeutic target for OA, highlighting its role in disease pathogenesis.
Area of Science:
- Biochemistry
- Genetics
- Immunology
Background:
- Osteoarthritis (OA) is a prevalent degenerative joint disease with largely unknown causes.
- The role of Zinc Finger Protein 652 (ZNF652), a known transcription factor, in OA pathogenesis remains uninvestigated.
Purpose of the Study:
- To investigate the potential role of ZNF652 in osteoarthritis.
- To identify ZNF652 as a potential diagnostic and therapeutic target for OA.
Main Methods:
- Transcriptome data from OA patients and healthy individuals were analyzed to identify differentially expressed genes (DEGs) using machine learning.
- The diagnostic accuracy of DEGs was assessed via Receiver Operating Characteristic (ROC) curve analysis.
- ZNF652 expression was validated in OA rat cartilage using qRT-PCR and Western blotting.
Main Results:
- ZNF652 was identified as a significant DEG with high diagnostic value for OA.
- Enrichment analyses indicated ZNF652's involvement in nitric oxide anabolism, macrophage proliferation, immune response, and PI3K/Akt and MAPK signaling pathways.
- Validation confirmed significantly increased ZNF652 expression in OA cartilage.
Conclusions:
- ZNF652 is implicated in OA pathogenesis and shows potential as a diagnostic and therapeutic target.
- ZNF652's mechanism involves regulating nitric oxide, macrophage activity, signaling pathways, and immune cell functions in OA.
- Further clinical validation and mechanistic studies are warranted.

